Evercore ISI Group Maintains In-Line on Edwards Lifesciences, Lowers Price Target to $70
Portfolio Pulse from Benzinga Newsdesk
Evercore ISI Group has maintained an In-Line rating on Edwards Lifesciences but lowered the price target from $76 to $70.
October 01, 2024 | 4:30 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Evercore ISI Group has maintained an In-Line rating on Edwards Lifesciences but lowered the price target from $76 to $70, indicating a more cautious outlook.
The lowering of the price target from $76 to $70 by Evercore ISI Group suggests a more cautious outlook on Edwards Lifesciences' stock performance. This could lead to a negative short-term impact on the stock price as investors may adjust their expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100